ANNX logo

Annexon, Inc. (ANNX)

Profile

Full Name

Annexon, Inc.

Ticker

NASDAQ: ANNX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2020

Indexes

Not included

Website

https://www.annexonbio.com

Employees

106

Key Details

Price

$2.31(+6.45%)

Market cap

$253.84M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.01(+42.94% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.31
    ANNX price is $2.31

    30-Day Relative Volume

    1.52
    ANNX 30-day relative volume is 1.52

    Price Performance

    Price Most recent change

    +6.45%
    ANNX price was up +6.45% on Aug 22, 2025

    Price YTD change

    -54.97%
    ANNX price is down -54.97% since January 1st

    Price 1-year change

    -60.78%
    ANNX price is down -60.78% year-on-year

    Price 3-year change

    -56.9%
    ANNX price is down -56.9% over the past 3 years

    Price Range

    Price All-time high

    $38.01
    ANNX price is currently -93.92% below its historical high of $38.01

    Price 3-year low

    $1.28
    ANNX price is currently +79.77% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $253.84M
    ANNX market capitalization is $253.84 million

    Market cap 3-year change

    -0.55%
    ANNX market capitalization is down -0.55% over the past 3 years

    Market cap All-time high

    $1.34B
    ANNX market capitalization is currently -81.00% below its historical high of $1.34 billion

    Market cap sector rank

    54.18%
    ANNX market capitalization is higher than 54.18% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.01%
    ANNX shares outstanding is up +4.01% year-on-year

    Shares Outstanding 3-Year Change

    +130.77%
    ANNX shares outstanding is up +130.77% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.98
    ANNX beta is 0.98

    200-day SMA

    $2.34
    ANNX price is currently -1.16% below its 200-day simple moving average

    50-day SMA

    $2.34
    ANNX price is currently -1.16% below its 50-day simple moving average

    RSI

    46.97
    ANNX 14-day relative strength index is 46.97

    Volume

    1.52
    ANNX 30-day relative volume is 1.52

    ATR

    $0.19
    ANNX average true range is $0.19

    10-day Historical Volatility

    82.74%
    ANNX 10-day historical volatility is 82.74%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ANNX annual revenue is $0.00

    Revenue Analysts estimate

    -
    ANNX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ANNX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.78%
    ANNX annual revenue is higher than 28.78% of companies in Healthcare sector

    EPS

    EPS

    -$1.01
    ANNX annual earnings per share is -$1.01

    EPS Analysts estimate

    -$1.40
    ANNX annual earnings per share is currently -27.99% lower than the consensus analysts' forecast

    EPS 1-year change

    +42.94%
    ANNX annual earnings per share is up +42.94% year-on-year

    EPS Sector rank

    52.03%
    ANNX annual earnings per share is higher than 52.03% of companies in Healthcare sector

    Profit

    Gross profit

    -$3.45M
    ANNX annual gross profit is -$3.45 million

    Gross margin

    -
    ANNX annual gross profit margin value is unknown

    Operating profit

    -$154.07M
    ANNX annual operating income is -$154.07 million

    Operating margin

    -
    ANNX annual operating profit margin value is unknown

    Net income

    -$138.20M
    ANNX annual net profit is -$138.20 million

    Net margin

    -
    ANNX annual net profit margin value is unknown

    Expenses

    Total expenses

    $138.20M
    ANNX annual total expenses is $138.20 million

    Operating expenses

    $150.62M
    ANNX annual total operating expenses is $150.62 million

    Cost of goods sold

    $3.45M
    ANNX annual cost of goods sold is $3.45 million

    Selling, general & administrative expenses

    $0.00
    ANNX annual SGA is $0.00

    Depreciation and amortization

    $3.45M
    ANNX annual depreciation & amortization is $3.45 million

    Interest expense

    $0.00
    ANNX annual interest expense is $0.00

    Income tax

    $0.00
    ANNX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$154.07M
    ANNX annual earnings before interest & taxes is -$154.07 million

    EBITDA

    -$150.62M
    ANNX annual EBITDA is -$150.62 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $350.07M
    ANNX annual total assets is $350.07 million

    Non current assets

    $33.61M
    ANNX annual long term assets is $33.61 million

    Current assets

    $316.46M
    ANNX annual total current assets is $316.46 million

    Cash and cash equivalents

    $312.02M
    ANNX annual cash & cash equivalents is $312.02 million

    Accounts receivable

    -
    ANNX annual accounts receivable value is unknown

    Inventory

    $0.00
    ANNX annual inventory is $0.00

    Liabilities

    Total liabilities

    $56.97M
    ANNX annual total liabilities is $56.97 million

    Long term liabilities

    $26.45M
    ANNX annual total long term liabilities is $26.45 million

    Current liabilities

    $30.51M
    ANNX annual total current liabilities is $30.51 million

    Accounts payable

    $10.43M
    ANNX annual accounts payable is $10.43 million

    Debt

    Total debt

    $28.97M
    ANNX annual total debt is $28.97 million

    Total debt 1-year change

    -7.6%
    ANNX annual total debt is down -7.6% year-on-year

    Long term debt

    $26.45M
    ANNX annual long term debt is $26.45 million

    Short term debt

    $2.52M
    ANNX annual short term debt is $2.52 million

    Equity & Capital

    Shareholders equity

    $293.11M
    ANNX annual stockholders equity is $293.11 million

    Book value

    $293.11M
    ANNX annual book value is $293.11 million

    Retained earnings

    -$710.70M
    ANNX annual retained earnings is -$710.70 million

    Working capital

    $285.95M
    ANNX annual working capital is $285.95 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$118.01M
    ANNX annual cash flow from operations is -$118.01 million

    Cash from operations 1-year change

    +2.59%
    ANNX annual cash flow from operations is up +2.59% year-on-year

    Cash from investing

    -$218.80M
    ANNX annual cash flow from investing activities is -$218.80 million

    Cash from investing 1-year change

    -409.46%
    ANNX annual cash flow from investing activities is down -409.46% year-on-year

    Cash from financing

    $161.21M
    ANNX annual cash flow from financing activities is $161.21 million

    Cash from financing 1-year change

    +18.95%
    ANNX annual cash flow from financing activities is up +18.95% year-on-year

    CAPEX

    CAPEX

    $15.00K
    ANNX annual capital expenditures is $15.00 thousand

    CAPEX 1-year change

    -92.23%
    ANNX annual capital expenditures is down -92.23% year-on-year

    Free Cash Flow

    Free cash flow

    -$118.02M
    ANNX annual free cash flow is -$118.02 million

    Free cash flow 1-year change

    +2.73%
    ANNX annual free cash flow is up +2.73% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ANNX annual gross profit margin value is unknown

    Operating margin

    -
    ANNX annual operating profit margin value is unknown

    Net margin

    -
    ANNX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -42.67%
    ANNX annual return on assets is -42.67%

    ROE

    -50.84%
    ANNX annual return on equity is -50.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ANNX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ANNX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.28
    ANNX price to book ratio is 1.28

    PB ratio Sector rank

    40.73%
    ANNX price to book ratio is higher than 40.73% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ANNX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ANNX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $54.45M
    ANNX enterprise value is $54.45 million

    Enterprise value Sector rank

    41.12%
    ANNX enterprise value is higher than 41.12% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.28
    ANNX EV/EBITDA is -0.28

    EV/EBITDA Sector rank

    58.18%
    ANNX EV/EBITDA is higher than 58.18% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.37
    ANNX annual current ratio is 10.37

    Quick ratio

    10.37
    ANNX annual quick ratio is 10.37

    Leverage

    Debt to equity

    0.10
    ANNX annual debt to equity ratio is 0.10

    Interest coverage ratio

    -
    ANNX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ANNX piotroski f-score value is unknown

    Altman Z-Score

    -0.64
    ANNX altman z-score is -0.64

    Analyst ratings

    Recent major analysts updates

    Aug 15, 25 HC Wainwright & Co.
    Buy
    May 14, 25 HC Wainwright & Co.
    Buy
    May 13, 25 Needham
    Buy
    Mar 4, 25 Needham
    Buy
    Dec 17, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 Needham
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 Cantor Fitzgerald
    Overweight
    Sep 9, 24 Cantor Fitzgerald
    Overweight
    Aug 13, 24 Needham
    Buy

    Institutional Ownership

    Screeners with ANNX included

    Growing Shares Outstanding
    US stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Best performing stocks last 3 months
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    Small cap stocks
    Most recommended stocks
    • What is the ticker symbol for Annexon, Inc.?
    • Does Annexon, Inc. pay dividends?
    • What sector is Annexon, Inc. in?
    • What industry is Annexon, Inc. in?
    • What country is Annexon, Inc. based in?
    • When did Annexon, Inc. go public?
    • Is Annexon, Inc. in the S&P 500?
    • Is Annexon, Inc. in the NASDAQ 100?
    • Is Annexon, Inc. in the Dow Jones?
    • When was Annexon, Inc.'s last earnings report?
    • When does Annexon, Inc. report earnings?

    What is the ticker symbol for Annexon, Inc.?

    The ticker symbol for Annexon, Inc. is NASDAQ:ANNX

    Does Annexon, Inc. pay dividends?

    No, Annexon, Inc. does not pay dividends

    What sector is Annexon, Inc. in?

    Annexon, Inc. is in the Healthcare sector

    What industry is Annexon, Inc. in?

    Annexon, Inc. is in the Biotechnology industry

    What country is Annexon, Inc. based in?

    Annexon, Inc. is headquartered in United States

    When did Annexon, Inc. go public?

    Annexon, Inc.'s initial public offering (IPO) was on July 24, 2020

    Is Annexon, Inc. in the S&P 500?

    No, Annexon, Inc. is not included in the S&P 500 index

    Is Annexon, Inc. in the NASDAQ 100?

    No, Annexon, Inc. is not included in the NASDAQ 100 index

    Is Annexon, Inc. in the Dow Jones?

    No, Annexon, Inc. is not included in the Dow Jones index

    When was Annexon, Inc.'s last earnings report?

    Annexon, Inc.'s most recent earnings report was on August 14, 2025

    When does Annexon, Inc. report earnings?

    The next expected earnings date for Annexon, Inc. is November 13, 2025
    On this page